Anti–PD-1 therapy (pembrolizumab, nivolumab) supports neoadjuvant and adjuvant management of higher-risk melanoma, offering durable remissions with less systemic toxicity than traditional chemotherapy ...
Receiving a diagnosis of squamous cell carcinoma (SCC) can be an overwhelming experience, but it is important to remember ...
Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or nonmelanoma skin cancer, which is also known as keratinocyte ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Samuel J. Klempner ...
Recent findings suggest no significant overall survival difference for patients with locally advanced esophageal squamous cell carcinoma who had neoadjuvant vs adjuvant therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results